| The impact of choosing wisely interventions on Low‐Value medical services: a systematic review BQ Cliff, ALV Avancena, RA Hirth, SYD Lee The Milbank Quarterly 99 (4), 1024-1058, 2021 | 114 | 2021 |
| The economics of malaria control and elimination: a systematic review R Shretta, ALV Avanceña, A Hatefi Malaria journal 15, 1-14, 2016 | 74 | 2016 |
| Engaging the private sector in malaria surveillance: a review of strategies and recommendations for elimination settings A Bennett, ALV Avanceña, J Wegbreit, C Cotter, K Roberts, R Gosling Malaria journal 16, 1-19, 2017 | 54 | 2017 |
| Examining equity effects of health interventions in cost-effectiveness analysis: a systematic review ALV Avanceña, LA Prosser Value in Health 24 (1), 136-143, 2021 | 46 | 2021 |
| Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis ALV Avanceña, N Miller, SE Uttal, DW Hutton, JL Mellinger Journal of hepatology 74 (6), 1286-1294, 2021 | 36 | 2021 |
| Income and income inequality are a matter of life and death. What can policymakers do about it? ALV Avancena, EK DeLuca, B Iott, A Mauri, N Miller, D Eisenberg, ... American Journal of Public Health 111 (8), 1404-1408, 2021 | 29 | 2021 |
| Malaria elimination transmission and costing in the Asia-Pacific: Developing an investment case R Shretta, SP Silal, OJ Celhay, CEG Mercado, SS Kyaw, A Avancena, ... Wellcome Open Research 4, 2019 | 23 | 2019 |
| An investment case to prevent the reintroduction of malaria in Sri Lanka R Shretta, R Baral, ALV Avanceña, K Fox, AP Dannoruwa, R Jayanetti, ... The American journal of tropical medicine and hygiene 96 (3), 602, 2017 | 20 | 2017 |
| Unintended consequences and hidden obstacles in medicine access in Sub-Saharan Africa I Barton, ALV Avanceña, N Gounden, R Anupindi Frontiers in Public Health 7, 342, 2019 | 18 | 2019 |
| The costs and health benefits of expanded access to MDMA-assisted therapy for chronic and severe PTSD in the USA: a modeling study ALV Avanceña, JG Kahn, E Marseille Clinical Drug Investigation 42 (3), 243-252, 2022 | 14 | 2022 |
| Innovations in cost-effectiveness analysis that advance equity can expand its use in health policy ALV Avanceña, LA Prosser BMJ Global Health 7 (2), e008140, 2022 | 12 | 2022 |
| Adult vaccination uptake strategies in low-and middle-income countries: A systematic review JM Perroud, S Soldano, ALV Avancena, A Wagner Vaccine 40 (36), 5313-5321, 2022 | 10 | 2022 |
| Optimization models for HIV/AIDS resource allocation: A systematic review ALV Avanceña, DW Hutton Value in Health 23 (11), 1509-1521, 2020 | 9 | 2020 |
| Mapping healthcare systems: a policy relevant analytic tool N Sekhri Feachem, A Afshar, C Pruett, ALV Avanceña International health 9 (4), 252-262, 2017 | 9 | 2017 |
| Cost-effectiveness analysis of a physician deployment program to improve access to healthcare in rural and underserved areas in the Philippines ALV Avanceña, KPS Tejano, DW Hutton BMJ open 9 (12), e033455, 2019 | 7 | 2019 |
| Social Franchises: The Bridge Between Healthcare Providers and National Health Insurance Programs: Lessons Learned from Two Initiatives in the Philippines R Viswanathan, A Avancena San Francisco: University of California, San Francisco, 2015 | 4 | 2015 |
| Achieving malaria testing and treatment targets for children under five in Mozambique: a cost-effectiveness analysis ALV Avanceña, A Miller, N Canana, J Dula, A Saifodine, B Cadrinho, ... Malaria Journal 21 (1), 320, 2022 | 2 | 2022 |
| Cost‐effectiveness of implantable ventricular assist devices in older children with stable, inotrope‐dependent dilated cardiomyopathy ALV Avanceña, DW Hutton, J Lee, KR Schumacher, MS Si, DM Peng Pediatric Transplantation 25 (4), e13975, 2021 | 2 | 2021 |
| The private sector’s role in malaria surveillance. UCSF A Bennett, ALV Avanceña, J Wegbreit, C Cotter, K Roberts, RD Gosling Global health science, 2014 | 2 | 2014 |
| Association Between Alcohol Use Disorder and Hospital Readmission Rates and Outcomes in Cancer Survivors: A Population Cohort Study JH Lai, S Han, C Park, ALV Avanceña Journal of the National Comprehensive Cancer Network 22 (1), 2024 | 1 | 2024 |
